At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 170 enrolled
Drug / intervention
Celecoxib +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Control Trial Study of the Efficacy of Celecoxib Versus Ketorolac for Perioperative Pain Control
In Brief
A Phase 2 clinical trial evaluating Celecoxib and Ketorolac for Pain, Postoperative. Completed, enrolled 170 participants across 1 site.
Detailed Summary
Randomized control trial between ketorolac versus celecoxib for postoperative pain following hysterectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
Primary CompletionJun 2016
Study CompletionJan 2017
First PostedNov 2017
TodayJul 2026
First PostedNov 6, 2017
Enrollment StartSep 1, 2013
Primary CompletionJun 30, 2016
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 8.7 years ago
Interventions
Celecoxibdrug
Ketorolacdrug